Share-Based Compensation - Summary Activity in shares Subjected to Options and Weighted Average Exercise Prices (Details) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
BYB Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Shares, Beginning balance	1,337,048
Number of Shares, Exercised	(520,988)	(53,531)
Number of Shares, Ending balance	816,060	1,337,048
Number of Shares, Exercisable	816,060
Weighted Average Exercise Price, Beginning balance | $ / shares	$ 11.26
Weighted Average Exercise Price, Exercised | $ / shares	11.18
Weighted Average Exercise Price, Ending balance | $ / shares	11.30	$ 11.26
Weighted Average Exercise Price, Exercisable | $ / shares	$ 11.30
Intrinsic Value, Beginning balance | $	$ 21,519
Intrinsic Value, Exercised | $	7,742
Intrinsic Value, Ending balance | $	10,197	$ 21,519
Intrinsic Value, Exercisable | $	$ 10,197
Weighted Average Remaining Contractual Term (in Years)	3 years	3 years 6 months
Weighted Average Remaining Contractual Term (in Years), Exercisable	3 years
FEB Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Shares, Beginning balance	170,697
Number of Shares, Exercised	0	(62,366)
Number of Shares, Ending balance	170,697	170,697
Number of Shares, Exercisable	170,697
Weighted Average Exercise Price, Beginning balance | $ / shares	$ 11.60
Weighted Average Exercise Price, Ending balance | $ / shares	11.60	$ 11.60
Weighted Average Exercise Price, Exercisable | $ / shares	$ 11.60
Intrinsic Value, Beginning balance | $	$ 2,688
Intrinsic Value, Ending balance | $	2,082	$ 2,688
Intrinsic Value, Exercisable | $	$ 2,082
Weighted Average Remaining Contractual Term (in Years)	2 years 10 months 24 days	3 years 4 months 24 days
Weighted Average Remaining Contractual Term (in Years), Exercisable	2 years 10 months 24 days